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ABSTRACT
MicroRNAs (miRNAs) have emerged as key regula-
tors of gene expression. Intragenic miRNAs account
for  50% of mammalian miRNAs. Classic studies
reported that they are usually coexpressed with
host genes. Here, using genome-wide miRNA and
gene expression profiles from five sample sets, we
show that evolutionarily conserved (‘old’) intragenic
miRNAs tend to be coexpressed with host genes,
but non-conserved (‘young’) ones rarely do so.
This result is robust: in all sample sets, the coex-
pression rate of young miRNAs is significantly
lower than that of conserved ones even after
controlling for abundance. As a result, although
young miRNAs dominate in human genome, the
majority of intragenic miRNAs that show coex-
pression with host genes are phylogenetically old
ones. For younger miRNAs, extrapolation of their
expression profiles from those of their host genes
should be treated with caution. We propose a model
to explain this phenomenon in which the majority
of young miRNAs are unlikely to be coexpressed
with host genes; however, for some fraction of
young miRNAs coexpression with their host genes,
initially imbued by chromatin level effects, is advan-
tageous and these are the ones likely to embed
into the system and evolve ever higher levels of
coexpression, possibly by evolving piggybacking
mechanisms.
INTRODUCTION
Evidence is emerging that microRNAs (miRNAs), an
abundant class of small ( 22nt) non-coding RNAs, are
key regulators of gene expression in both health and
disease (1–9). Around 50% of the mammalian miRNAs
are located within introns or exons of protein-coding
genes and on the same strand (10–13). Most of these
same-strand intragenic miRNAs are located within
introns of host genes and are referred to as intronic
miRNAs, whereas the remaining small portion are
overlapping with exons of their host genes and are thus
called exonic miRNAs. MiRNAs on the opposite strand
are also known. Unless stated otherwise, our analysis con-
siders only sense strand intronic and exonic miRNAs.
Early evidence suggested that intragenic miRNAs and
host mRNAs might be processed from the same RNA
substrate (14). In analyses of expressed sequence tag
(EST) libraries, a population of chimeric miRNA
precursor-mRNA transcripts were observed in normal
human and mouse tissues (15), and some EST fragments
that are located either immediately upstream or down-
stream of miRNAs were partially spliced, with either
50-o r3 0-ends matching the putative Drosha cleavage
sites (16). In addition, some studies indicated that the bio-
genesis of intronic miRNAs were enhanced in the presence
of ﬂanking exons (17) and that some miRNA micropro-
cessor complex-associated proteins were identiﬁed also as
splicing factors or involved in pre-mRNA processing
(14,18–20). More importantly, several previous studies
showed that intragenic miRNAs are often coexpressed
with their host genes (10,21,22). Thus, a commonly con-
sidered model was proposed suggesting that mammalian
intragenic miRNAs are derived from the same primary
transcripts as, and thereby are coexpressed with their
host genes (14–16,21,23–28).
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at least three reasons. First, it suggests that miRNAs
commonly piggy-back on the transcription of the host
gene rather than have their own independent promoters.
Consequently, disruption to the expression of the host
gene is likely to result in disruption to the expression of
the miRNA making the phenotypic impact of such disrup-
tion both more acute and more complex. Second, based on
this model, expression proﬁles of host genes are used as
surrogates for those of the intragenic miRNAs to predict
miRNA target genes (29–32). If not true, however, this
shortcut cannot be defended and all prior results derived
from this assumption would require reappraisal. Third,
the model suggests a potentially important mode of regu-
lation in which upregulation of one gene (containing the
miRNA) by necessity leads to downregulation of others
(the targets of the embedded miRNA). Thus, we might
expect the protein-coding genes containing miRNAs that
are upregulated to have opposite functions to those
downregulated by the miRNAs. Thus, there might be a
logic as to which miRNAs are in which genes. However, if
miRNA and host gene are not coexpressed as frequently
as observed in the previous studies, then such coupling is
not expected.
Previous results, however, were derived from expression
studies of only a small number (<35) of intragenic
miRNAs. In fact, using recent versions of miRBase and
human genome annotation, we identiﬁed over 600 possible
human intragenic miRNAs, although many are of uncer-
tain validity. Here, then we re-evaluate the correlation of
expression between intragenic miRNAs and their host
genes. Our analysis is based on genome-wide miRNA
and gene array data from ﬁve human sample sets that
we experimentally derived or we collected from publically
available databases. Our results suggest that evolution-
arily conserved intragenic miRNAs do tend to be
coexpressed with their host genes, but, in contrast,
poorly conserved ones rarely do so. We do not wish to
assert that these young ones are or are not coexpressed
with their host genes as the answer to this would be sen-
sitive to, among other details, which tissues are analyzed.
Rather, we wish to point out a difference between young
and old miRNAs in the likelihood that their expression is
closely coupled with that of their host. Further to this
ﬁnding, we then propose an evolutionary model in
which miRNAs can undergo an embedding process, part
of which can be increase in coordination in expression
between the miRNA and the host gene.
MATERIALS AND METHODS
Annotation of intragenic miRNAs and host genes
We focused on intragenic miRNAs that are located within
genes with reference sequences (RefSeqs), as those without
Refseq might not be well annotated. Furthermore, accord-
ing to a common criterion (23), only the miRNAs that
have the same orientation with their host genes were
counted as intragenic miRNAs. The University of
California Santa Cruz (UCSC) Genome Browser (human
genome hg19), RefSeq mRNA annotation and miRBase
(Release 17) miRNA annotation were used to identify
intronic and exonic miRNAs.
miRNA and mRNA expression proﬁling assays and data
normalization
An in-house sample set including 81 human primary acute
myeloid leukemia patient samples was used in this study.
Exiqon miRCURY LNA
TM Arrays (v11.0; covering over
1000 human) and Affymetrix Human Exon 1.0 ST Arrays
were used to produce miRNA and mRNA expression
proﬁling, respectively. See Supplementary Information
for details about the data normalization. The data set
has been deposited at GEO database (GSE27370; www.
ncbi.nlm.nih.gov/geo/).
In addition, we obtained four data sets from GEO
database (accession numbers GSE17306, GSE20161,
GSE19783, GSE21032), which include miRNA and
mRNA expression proﬁles of human myeloma (n=52;
primary patient samples), EBV transformed lympho-
blastoid cell (n = 90; cell lines), breast cancer (n=101;
primary patient samples) and prostate (n=139; human
primary and metastatic prostate cancer samples and
control normal adjacent benign prostate) samples.
Agilent Human miRNA arrays, Illumina Human
miRNA beadchip, Agilent Human Genome Microarray
(probe name version), Affymetrix Human Genome U133
Plus 2.0 Array, Affymetrix Human Exon 1.0 ST arrays
and Illumina Human expression beadchip, respectively,
were used to derive the miRNA and gene expression
proﬁles (33–36). For data set GSE21032, the data normal-
ization were performed as described above. For data sets
GSE17306, GSE20161 and GSE19783, we used their own
normalized intensity.
Data analyses and statistics
Pearson’s product-moment correlation was used to assess
expression correlation between intragenic miRNAs and
host genes (the sample number of each tissue was
described above as well as in Tables 2–4). P<0.05 was
considered as signiﬁcant. Evolutionary conservation infor-
mation of miRNAs was downloaded from TargetScan
(37) (http://www.targetscan.org/). Partek Genomics Suite
(Partek Inc, St Louis, MI, USA), WinSTAT (R. Fitch
Software; Bad Krozingen, Germany) and Bioconductor
R packages were used for the data and statistics analyses.
Database set up
To facilitate examination of the genomic loci of the
intragenic miRNAs and their position relationship with
corresponding host genes, as well as the positions of the
probes of the host genes included in the Affymetrix exon
arrays, we also developed a web-based database (http://
chenlab.uchicago.edu/database/intragenic_mir.php).
RESULTS
Identiﬁcation of intragenic miRNAs and host genes from
the human genome
Based on RefSeq mRNA annotation (human genome
hg19) in UCSC Genome Browser and miRNA annotation
Nucleic Acids Research,2012, Vol.40, No. 9 4003in miRBase (Release 17), we identiﬁed 657 human
intragenic miRNAs that are embedded within genomic
loci of 594 human RefSeq genes, respectively (Table 1
and Supplementary Table S1). Of them, 552 (84%)
human intragenic miRNAs are intronic miRNAs,
which are located in the introns of their host genes,
whereas 105 (16%) human intragenic miRNAs are
overlapping with exons of their host genes and thereby
are referred to as exonic miRNAs (Table 1 and
Supplementary Table S1).
In contrast to prior reports that exonic miRNAs solely
overlapping with exons of non-coding genes (10,38), we
ﬁnd that the host genes of exonic miRNAs are mainly
protein-coding genes. As shown in Supplementary Table
S2, 82% (86/105) of the unique host genes of the exonic
miRNAs are protein-coding genes, whereas only 18%
(19/105) are non-coding RNAs.
According to the criteria of TargetScan (37) (http://
www.targetscan.org/), we classiﬁed intragenic miRNAs
into two subgroups based on their evolution conservation
degrees, including ‘conserved’ (i.e. those that are
conserved across most mammals, including both ‘highly
conserved’ and ‘conserved’ ones annotated in Targetscan)
and ‘non-conserved’ ones (i.e. those that are identiﬁed
as ‘poorly conserved’ in TargetScan). Among the 657
human intragenic miRNAs, 317 have conservation infor-
mation in TargetScan (37) (http://www.targetscan.org/)
and are thought to be highly reliable miRNAs. The re-
maining 340 miRNAs were not included in TargetScan.
Among the 317 intragenic miRNAs, we found that the
majority of intragenic miRNAs are ‘non-conserved’
ones: 209 (68%) are ‘non-conserved’, whereas only 98
(32%) are ‘conserved’ ones (Table 1). One may expect
that most of the remaining 340 miRNAs might also be
‘non-conserved’ ones. Thus, these results accord with the
notion that miRNAs are both readily gained and readily
lost, resulting in an excess of young, non-conserved
miRNAs (39,40).
Only a small fraction of intragenic miRNAs are likely
coexpressed with their host genes in human leukemia
samples
The concept that intragenic miRNAs are always
coexpressed with their host genes was largely derived
from several previous studies that focused on only a
small number of intragenic miRNAs (10,21,22). For
example, Rodriguez et al. (10) and Ronchetti et al. (22)
experimentally assessed expression correlation of ﬁve (i.e.
miR-9-3, miR-22, miR-137, miR-153 and miR-219-2) and
three (miR-335, miR-342-3p and miR-561) intragenic
miRNAs with their host genes, respectively. The largest
set previously reported, the study of Baskerville and Bartel
(21), focused on 34 intragenic miRNAs. In addition, since
in early studies evolutionary conservation was used as a
common criterion in identiﬁcation of miRNAs (41,42), all
miRNAs (including intragenic miRNAs) identiﬁed early
on are almost exclusively evolutionarily conserved ones.
Indeed, all the ﬁve miRNAs studied by Rodriguez et al.
(10) and two of the three miRNAs studied by Ronchetti
et al. (22) are ‘conserved’ ones. Of the 34 miRNAs studied
by Baskerville and Bartel (21), 31 (91%) are ‘conserved’
and only 3 (9%) are ‘non-conserved’ ones.
As hundreds of intragenic miRNAs have been identiﬁed
in mammalian genomes now and the majority of them are
poorly conserved ones (Table 1), it is important to deter-
mine whether the current conception that most of the
intragenic miRNAs are coexpressed with host genes is
still true when we assess expression correlation of a
much larger number of intragenic miRNAs with their
host genes, and whether poorly conserved (i.e. ‘new’)
intragenic miRNAs exhibit a similar trend in coexpression
with their host genes as the evolutionarily conserved ones.
To this end, we conducted both miRNA and mRNA
expression proﬁling assays of 81 human primary leukemia
samples by use of Exiqon miRNA arrays and Affymetrix
exon arrays, respectively (‘Materials and Methods’
section). We obtained reliable expression proﬁles for 240
intragenic miRNAs and their host genes. Surprisingly, we
found that only 24% (58) of the 240 intragenic miRNAs
exhibited a signiﬁcantly positive correlation (P<0.05,
Pearson Correlation) of expression with their host genes
(Table 2). After controlling for the probability of false
positives (type I errors), 9% (21/240) of the intragenic
miRNAs are coexpressed (adjusted P<0.05, Bonferroni
correction) with their host genes.
The discrepancy between our observation and the previous
reports is likely attributed to the difference in proportions
of conserved intragenic miRNAs
There was no P-value available in the Baskerville and
Bartel set (21), but if we deﬁne a coexpressed pair as a
pair of intragenic miRNA and host gene with a correlation
coefﬁcient of expression (i.e. r)>0.3, 26 out of the 34 (i.e.
76%) intragenic miRNAs are coexpressed with their host
genes in the Baskerville and Bartel set, which is signiﬁcant-
ly higher (P<0.0001, chi-square test) than that (24%) we
observed in our human leukemia set.
Tissue type and expression proﬁling technology differ-
ences might be able to explain part of the large
Table 1. Statistics of human intragenic miRNAs
All (number of unique host genes) 657 (594)
Genomic location, n (%)
Intronic 552 (84)
Exonic 105 (16)
Evolutionary conservation
a
Conserved 98 (32%)
Intronic 89
Exonic 9
Non-conserved 209 (68%)
Intronic 175
Exonic 34
aThe conservational subtypes were classed according to the
categories of TargetScan (37) (Release 5.1; http://www.targetscan.
org/). The ‘Highly conserved’ and ‘Conserved’ miRNAs were referred
as ‘Conserved’ ones, that are conserved across most mammals.
The ‘poorly conserved’ miRNAs were referred as ‘Non-Conserved’
ones. A total of 317 intragenic miRNAs have conservation information
in TargetScan. The remaining 340 intragenic miRNAs were not
included in TargetScan (37), and were excluded from our further
analyses.
4004 Nucleic Acids Research, 2012,Vol.40, No. 9discrepancy. However,  90% (31/34) of intragenic
miRNAs studied by Baskerville and Bartel are conserved
ones (21), and this ratio is signiﬁcantly (P<0.0001,
chi-square test) greater than that ( 33%; 78/240) in our
leukemia set (note: all the 240 intragenic miRNAs in
the leukemia set have conservation information from
TargetScan). Remarkably, we found that non-conserved
intragenic miRNAs have a much lower possibility to be
coexpressed with their host genes than conserved ones. As
shown in Table 2, only 11% (18/162) of the poorly
conserved intragenic miRNAs in our leukemia set are
likely coexpressed with their host genes, over four times
lower (P<0.0001, chi-square test) than the coexpression
rate (51%; 40/78) of the conserved ones. If only consider-
ing intragenic miRNAs included in the Baskerville and
Bartel set (21) in our leukemia set, the coexpression rate
would be dramatically increased from 24% (58/240) to
70% (19/27), close to that (76%) reported by Baskerville
and Bartel (21). Thus, our data indicate that evolutionar-
ily conserved intragenic miRNAs have a signiﬁcantly
(P<0.0001, chi-square test) higher possibility than
non-conserved ones in coexpression with host genes, and
that the discrepancy between our observation and the
previous reports is largely attributed to the difference in
proportions of conserved intragenic miRNAs.
Evolutionarily conserved intragenic miRNAs exhibit a
signiﬁcantly higher rate of coexpression with host genes
than non-conserved ones within and across individual sets
To examine the robustness and generality of our above
ﬁnding from human leukemia sample set, we obtained
miRNA and mRNA expression proﬁles of four additional
human sample sets from a public database (GEO;
‘Materials and Methods’ section); in each set, we have
more than 50 individual samples and over 90 intragenic
miRNA–host gene pairs (Table 2). We then correlated
expression of each intragenic miRNA with that of the
host gene in each sample set.
Although the rate of potential coexpression between
intragenic miRNAs and host genes varies greatly
between different data sets (e.g. only 16–24% in the
human leukemia, myeloma or lymphoblastoid cell
samples, but as high as 60% in both human breast
cancer and prostate samples; Pearson correlation; based
on raw P-values), we observed that conserved intragenic
miRNAs exhibited a signiﬁcantly (P<0.01, chi-square
test) higher rate of coexpression with their host genes
than non-conserved ones in each data set (Table 2 and
Figure 1; all the intragenic miRNAs with reliable expres-
sion values in each data set have conservation information
from TargetScan). On average, 53% (based on raw
P-values) or 30% (Bonferroni correction) of ‘conserved’,
whereas only 19% (based on raw P-values) or 10%
(Bonferroni correction) of ‘non-conserved’ intragenic
miRNAs are likely coexpressed with their host genes
across the ﬁve sample sets (P<0.05, Wilcoxon rank
test—based on either raw or adjusted P-values; Figure 1
and Table 2). The difference of coexpression rate between
‘conserved’ and ‘non-conserved’ subgroups was also
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Nucleic Acids Research,2012, Vol.40, No. 9 4005signiﬁcant (P<0.05, Wilcoxon rank test) in both intronic
and exonic miRNAs (Table 2).
As a result, the majority of the intragenic miRNAs
that are likely coexpressed with their host genes are evo-
lutionarily conserved ones in each data set (Table 2 and
Figure 2A). The fact that we can recover high
coexpression rates for conserved genes supports the view
that our coexpression scoring method is adequately
powerful to detect coexpression if it is present.
We also analyzed the coexpression probability of
each intragenic miRNA with its host gene across the
ﬁve sample sets. There are a total of 90 conserved and
189 non-conserved unique intragenic miRNAs that
have reliable expression proﬁles with their host genes
in at least one of the ﬁve sample sets (Supplementary
Table S3). As expected, conserved intragenic miRNAs
have a much higher possibility to be coexpressed with
their host genes across the ﬁve sample sets (Figure 2B
and Supplementary Table S3). For example, 74%
(67/90), 60% (54/90) and 37% (33/90) of the conserved
intragenic miRNAs are likely coexpressed with their host
genes in at least one, two and three sample sets, respect-
ively; in contrast, the ratios for non-conserved intragenic
miRNAs are 23% (44/189), 7% (13/189) and 2% (4/189),
respectively (Supplementary Table S3 and Figure 2B). The
average number of sample sets in which a given conserved
intragenic miRNA exhibits a signiﬁcant (raw P<0.05)
coexpression with its host gene is  2, signiﬁcantly
(P<0.05, Mann–Whitney U-test) greater than that (0.3)
of non-conserved intragenic miRNAs.
The higher coexpression rate in breast cancer or prostate
sample set is likely related to a higher proportion of
conserved intragenic miRNAs and some other factors
The higher coexpression rate in breast cancer or prostate
sample set (60%) than in other three data sets (16–24%) is
likely related with a higher proportion of conserved
intragenic miRNAs (Figure 3A). If only considering
miRNAs in breast cancer or prostate cancer sample set,
the coexpression rate was also increased in the other
three sample sets compared to that of entire miRNA set
(Figure 3B).
Nevertheless, even if considering similar sets of
intragenic miRNAs, the coexpression rates are not the
same between different sample sets (Figure 3B), suggesting
that some other factors may also have inﬂuence on
coexpression probability of intragenic miRNAs with
their host genes. For example, sample size (e.g. the
breast cancer and prostate sample sets have a greater
number of individual samples than the other three sets),
variability of sample types in each set (e.g. the prostate set
contains both tumor and normal control samples, whereas
the other sets have more unique sample types), and tissue
speciﬁcity (e.g. intragenic miRNAs may tend to be
coexpressed with host genes in some types of tissues
rather than in other types) may also have some inﬂuence.
The difference of coexpression rates between conserved
and non-conserved intragenic miRNAs is not due to
potential differences in abundance
One may argue that many poorly conserved miRNAs are
expressed at very low levels and are not detected reliably
by microarrays so that non-conserved intragenic miRNAs
exhibited a lower rate of coexpression with host genes as
detected by microarrays. In order to eliminate the
Figure 2. The majority or most of the coexpressed intragenic miRNAs
are conserved ones, which also exhibit coexpression with host genes in
more data sets than non-conserved ones. (A) Conservational distribu-
tion of coexpressed intragenic miRNAs in individual sample sets based
on the raw P-values. (B) Conservational distribution of the intragenic
miRNAs that exhibit coexpression (based on raw P-values) with their
host genes in more than one, more than two, more than three, more
than four and all the ﬁve sample sets, respectively.
Figure 1. Proportion of intragenic miRNAs that are likely coexpressed
with their host genes in each individual sample set and the average
proportions across the ﬁve sample sets. Based on the raw P-values.
4006 Nucleic Acids Research, 2012,Vol.40, No. 9potential effects of different expression abundance between
conserved and non-conserved intragenic miRNAs in
microarray experiments, we selected conserved and
non-conserved miRNA groups that have comparable
mean expression levels. As shown in Table 3, the range
and average expression abundance of the selected group of
non-conserved intragenic miRNAs are similar to those of
the selected group of conserved intragenic miRNAs in
each sample set.
Notably, we still observed signiﬁcantly (P<0.01,
chi-square test) higher coexpression rates between
intragenic miRNAs and their host genes in ‘conserved’
than in ‘non-conserved’ ones in each sample set: 51%
(27/53) of ‘conserved’ and 5% (3/61) of ‘non-conserved’
in leukemia sample set; 28% (20/72) of ‘conserved’ and
11% (4/35) of ‘non-conserved’ in myeloma sample set;
31% (13/42) of ‘conserved’ and 17% (15/88) of
‘non-conserved’ in lymphoblastoid cell line sample set;
80% (20/25) of ‘conserved’ and 36% (16/44) of
‘non-conserved’ in breast cancer sample set; 81% (17/21)
of ‘conserved’ and 27% (7/26) of ‘non-conserved’ in
prostate sample set, respectively (Table 3 and Figure 4).
On average, 54% of the ‘conserved’ intragenic miRNAs
are likely coexpressed with their host genes across the ﬁve
sample sets, signiﬁcantly (P<0.05, Wilcoxon rank test)
more frequent than the coexpression rate (19%) of
‘non-conserved’ ones.
To avoid the problem of arbitrarily classifying a
given miRNA as either coexpressed with its host gene
Figure 3. High rates of coexpression of intragenic miRNAs with host
genes in the breast cancer and prostate cancer sample sets are, at least
in part, related to the predominance of ‘conserved’ intragenic miRNAs.
(A) Proportions of ‘conserved’ and ‘non-conserved’ intragenic miRNAs
in the ﬁve sample sets. (B) Proportion of intragenic miRNAs that
coexpressed with their host genes when using intragenic miRNAs
from the breast cancer set and prostate cancer sample set, respectively.
Based on raw P-values.
Table 3. Comparison of rates of coexpression with host genes between selected groups of conserved and non-conserved intragenic miRNAs
Intragenic miRNAs Leukemia sample set
(n=81)
Myeloma sample set
(n=52)
Lymphoblastoid cell
sample set (n=90)
Breast cancer sample
set (n=101)
Prostate sample set
(n=139)
Conserved
Number of miRNAs 53 72 42 25 21
Expression range 0.1–1.09 0.02–8.96 2.65–12.17 1.12–6.77 2.04–7.23
Average expression level 0.36 2.88 6.38 3.89 5.92
Rate of coexpression with
host genes, n/N (%)
27/53 (51) 20/72 (28) 13/42 (31) 20/25 (80) 17/21 (81)
Non-conserved
Number of miRNAs 61 35 88 44 26
Expression range 0.1–0.79 0.42–8.49 2.68–15.4 0.78–10.92 4.00–10.35
Average expression level 0.34 2.87 6.12 3.95 5.93
Rate of coexpression with
host genes, n/N (%)
3/61 (5) 4/35 (11) 15/88 (17) 16/44 (36) 7/26 (27)
Figure 4. Comparison of rates of coexpression with host genes between
selected groups of conserved and non-conserved intragenic miRNAs
that have similar expression abundance in each sample set (Table 3).
Based on raw P-values.
Nucleic Acids Research,2012, Vol.40, No. 9 4007or not, we also consider for each of the ﬁve samples, an
ANCOVA in which we ask whether conserved miRNAs
have higher raw coexpression values than non-conserved
ones, controlling for abundance. For each of the ﬁve
samples, we started by testing for an interaction effect
(which would preclude the use of ANCOVA). In no case
did we observe a signiﬁcant interaction term (input
gene set the same as in Table 3). In all ﬁve samples,
we observe that conserved miRNAs have higher r values
than non-conserved ones, controlling for abundance
(Supplementary Figures S1–S5). From Fisher’s method,
we can combine these results to one chi-squared test
which is very highly signiﬁcant (Fisher’s method,
 
2=80.4, df=10, P<0.0001). The same is found if we
consider all genes, not just those matched for expression
level (Fisher’s method,  
2=82.8, df=10, P<0.0001).
We conclude that conserved miRNAs are consistently
more highly coexpressed than younger ones controlling
for any difference in abundance.
Sense strand intragenic miRNAs are more likely to be
coexpressed with their host genes than are antisense
miRNAs
Previous studies (43–47) suggest that genomically neigh-
boring genes tend to be coexpressed across tissues or
through time. For example, the coexpression of some
neighboring genes might be attributable to the open chro-
matin domain of that entire region (48–50), as supported
by transgene analysis (51). Similarly, coexpression of some
intragenic miRNAs and host genes might also be attrib-
utable to chromatin-level regulation, rather than sharing
primary transcripts. To evaluate the effect of chromatin-
level regulation on the rate of coexpression between
intragenic miRNAs and host genes, we assessed the cor-
relation of expression between antisense miRNAs, i.e.
those that reside on the opposite strand to protein-coding
sense strand, and the sense genes. By deﬁnition, the anti-
sense miRNAs cannot be driven off the same promoter
nor be splice products of the sense strand mRNA. As the
analysis is also using miRNAs, this approach also controls
for methodological noise.
We identiﬁed a total of 167 antisense miRNAs in the
human genome (Supplementary Tables S4 and S5).
Among them, 35, 23, 27, 13 and 13 antisense miRNAs
have expression values available in the human leukemia,
myeloma, lymphoblastoid cell, breast cancer and prostate
samples, respectively, along with expression values of their
corresponding sense genes. On average, only 13% (based
on raw P-values) or 4% (based on the adjusted P-values
via Bonferroni correction) of the antisense miRNAs are
likely coexpressed with the sense host genes (Table 4),
which is signiﬁcantly less frequent than do (sense)
intragenic miRNAs and host genes (on average, 53% or
30% based on the raw or adjusted P-values; Table 2) in
each sample set (P<0.01, Fisher’s exact test) or across the
ﬁve sample sets (P<0.05, Wilcoxon rank test). The differ-
ence of coexpression probability with host genes between
antisense and sense intragenic miRNAs is signiﬁcant
(on average, 13% versus 53%; P<0.05, Wilcoxon
rank test) in the conserved population, but not signiﬁcant
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in the non-conserved population.
Thus, our data suggest that the high frequency (on
average, 53%; Table 2) of coexpression between conserved
intragenic miRNAs and their host genes is likely largely
due to the sharing of promoters or primary transcripts,
whereas only a small fraction (13% out of the 53%;
derived from the coexpression rate between conserved
antisense intragenic miRNAs and sense host genes;
Table 4) of the signal of coexpression can be accounted
for in terms of shared chromosomal location. The low
frequency (on average, 19%; Table 2) of coexpression
between non-conserved intragenic miRNAs and their
host genes is likely partially (9% out of the 19%;
derived from the coexpression rate between non-conserved
antisense intragenic miRNAs and sense host genes;
Table 4) due to the shared chromosomal location, and
the remaining part might be also owing to the shared pro-
moters or primary transcripts, which might occur by
chance.
DISCUSSION
In contrast to the prior conception, that intragenic
miRNAs are always coexpressed with their host genes
due to sharing the same promoters or primary transcripts
(10,21,22), we showed here that not all types of intragenic
miRNAs have the same coexpression trend. We observed
that the probability of coexpression of intragenic miRNA
with host genes is strongly related to their evolutionary
conservation degree. Evolutionarily conserved intragenic
miRNAs have a much higher rate of coexpression with
host genes than poorly conserved ones (Table 2).
The covariance with age is important for several
reasons. First, the result runs contrary to the expectations
of prior analyses (52), which suppose that coexpression
between miRNA and host gene is the ancestral state and
necessary for the emergence of an miRNA. Second, the
age effect argues against a methodological problem. One
might suppose that as miRNA and mRNA are on
separate decay paths that we might never expect a correl-
ation between miRNA and mRNA levels even if piggy-
backing was occurring. If this is a bona ﬁde technical
problem, however, we should not expect to see any sys-
tematic patterns of coexpression associated with miRNA
age. Furthermore, as shown in Tables 2 and 4, intragenic
miRNAs (sense) exhibit a much (53% versus 13%;
>4-fold; P<0.05, Fisher’s exact test) higher rate of
coexpression with host genes than the antisense intragenic
miRNAs do with their sense genes. Such data suggest that
besides the shared chromatin regulation effect (as reﬂected
by the coexpression probability of antisense miRNAs with
sense genes), a certain number of intragenic miRNAs, par-
ticularly the evolutionarily conserved ones, may really
share promoters/primary transcripts with their host genes.
Why then do the old (i.e. conserved) intronic miRNAs
tend to be cotranscribed with their host genes more than
the new (i.e. non-conserved) ones? We suggest that most
new miRNAs are expressed serendipitously and weakly
but not necessarily always from the same transcripts as
the host genes. Some are coexpressed owing to shared
chromatin dynamics, just as some antisense miRNAs are
coexpressed with the corresponding sense genes. Let us
then conjecture that for some of these their coexpression
is beneﬁcial and selection favors them to be what we
might call ‘embedded’, meaning they evolve stronger
coexpression, which in turn favors conservation of
miRNA target sites on 30-UTRs of desirable target genes
(and possibly selection for undesirable targets to evolve
away from being targets). For instance, some intronic
miRNAs may functionally cooperate with their host
genes. Indeed, a ‘conserved’ miRNA, miR-338 has been
reported to be cotranscribed with its host gene,
apoptosis-associated tyrosine kinase (AATK), and more
importantly, exhibits functional cooperation with its
host gene by repressing genes that are functionally antag-
onistic to the host gene (27). The strong coexpression is
perhaps best achieved by sharing promoters/transcripts.
Eventually, then we see old intragenic miRNAs exhibiting
a greater possibility of being coexpressed with host genes
than the newer less embedded ones do. Antisense miRNA
cannot easily become embedded as they do not have the
option of coopting the sense transcripts nor the sense
promoter. This is by no means the only possible model
to explain our results. It could be that for a few miRNAs
sharing of the promoter and strong coexpression with the
host gene was the ancestral condition. It is not, however,
clear why these should necessarily also be more ancient. In
such an instance, we might also expect that among the set
of genes with young miRNAs we should see a bimodal
distribution of coexpression r values, such that some (tran-
script sharing ones) would be centered around a high
coexpression score and others around a much lower
value. However, when we test young miRNAs for devi-
ation from unimodality of the coexpression values for
each of the ﬁve samples, we see no evidence such deviation
[Hartigan and Hartigan dip test (53), P>0.05 in all
instances].
Assuming our results are as robust as they appear to be,
how then can we explain the two pre-eminent observations
that were the stimulus to the notion that young miRNAs
must piggy-back on their host genes (52)? First, that so
many miRNAs are intragenic (and young ones tend to
more commonly be intragenic). Second, that when they
are reported intragenically, there are approximately four
times more in the sense strand than antisense (657 versus
167 in humans, Table 1 and Supplementary Table S4).
As most of the genome is not protein coding, randomly
inserted/generated miRNA one would also expect to be in
intergene spacer. Similarly, the simplest null would predict
an equal number sense and antisense. For both observa-
tions, we can rule out ascertainment bias as most of the
miRNAs are identiﬁed from small RNA libraries without
pre-selection in recent years.
Both facts can, at least in part, be explained by the idea
that miRNAs are more likely to persist if they can have
their expression piggybacking on that of a host gene.
Nonetheless, as the majority of both sense and antisense
intragenic miRNAs are poorly conserved ones, the above
model cannot explain the two facts thoroughly. Perhaps,
we might also suppose that new sense and antisense
Nucleic Acids Research,2012, Vol.40, No. 9 4009intragenic miRNAs both have expression enabled largely
by being in open chromatin associated with transcription-
al activity of host genes; however, frequent RNA polymer-
ase collisions might select against intragenic antisense
transcripts, much as RNA polymerase DNA polymerase
collisions in bacteria is thought to affect strand bias (54).
As a result, even among poorly conserved intragenic
miRNAs, most of them are located in sense with the
host genes (Table 1 and Supplementary Table S4).
Meanwhile, that miRNAs are commonly intragenic
accords with the observation that miRNAs are enriched
in transposon-free regions that tend also to be domains
of high protein-coding density (55). There exist multiple
mutational/insertion bias models alongside selectionist
models to explain both observations. Perhaps, newly
created miRNAs are more likely to become expressed if
within a gene owing to being in open chromatin at some
point in time (whenever the host gene is in open chroma-
tin), expression of the miRNA being a minimal criterion
for its persistence? Alternatively, there might exist inser-
tion biases for miRNAs produced via retroposition-like
events, much as retroviruses often prefer to insert
near transcriptionally active genes (56). Alternatively,
if introns are under selection to have particular stem–
loop structures, perhaps to aid exon junction recognition,
they might be genomic sweet spots for the emergence of
miRNA-like structures (57). A better understanding of the
fate of very young miRNAs, where they come from, how
they become expressed should shed light on these issues.
Our data indicate that a fraction of conserved and the
majority of non-conserved intragenic miRNAs are
unlikely to be strongly coexpressed with their host genes,
which is accord with recent studies that have suggested
that over one-third of intronic miRNAs have their own
promoters (Polymerase II or III), whose expression occurs
independently from host gene transcription (11,12,58–61).
For examples, Fisher and colleagues (11) conducted nu-
cleosome positioning analyses (62) and chromatin
immunoprecipitation (ChIP)-chip assays (63) in two
human melanoma (UACC62 and MALME) lines and
one breast cancer (MCF7) cell line and observed that
one-third of intragenic miRNAs may have their own pro-
moters. Corcoran et al. (60) performed Polymerase II
ChIP-chip assays in A549 human lung epithelial cells
and showed that over 26% of the intragenic miRNAs
may be transcribed from their own Pol II promoters.
Similarly, Monteys et al. (12) observed that  35% of
intragenic miRNAs have upstream regulatory elements
consistent with Pol II (30%) or Pol III (5%) promoter
function in human genome. More importantly, they
further cloned intronic regions composed of miRNAs
and their upstream Pol II (for miR-107, miR-126,
miR-208b, miR-548f-2, miR-569 and miR-590) or Pol
III (for miR-566 and miR-128-2) sequences into a
promoterless plasmid, and conﬁrmed that miRNA expres-
sion occurs independent of host gene transcription (12).
In Caenorhabditis. elegans, Martinez et al. (59) conducted
genome-wide assays of promoters of 89 miRNAs (66% of
all predicted miRNAs) using transgenic promoter–
reporter constructs and their results indicated that
intronic miRNAs are likely controlled by their own,
rather than the promoters of host genes. Similarly, Isik
et al. (61) reported that over one-third of intronic
miRNAs in C. elegans have their own promoters and
could be transcribed independently from host genes.
Given the fact that on average over 50% of intragenic
miRNAs might not be coexpressed with host genes
(Table 2), we expect that probably more than one-third
of intragenic miRNAs may have their own promoters or
relevant transcriptional regulatory elements. It was
reported that miRNAs can be transcribed from promoters
located several kilobases away (60), and thus it is possible
that promoters of many intragenic miRNAs have not been
identiﬁed yet.
Given the above ﬁndings, caution should be paid to
those analyses in which expression proﬁles of host
genes were used as a proxy for the expression of the cor-
responding intragenic miRNAs, such as in the cases where
expression proﬁles of host genes were used to predict
miRNA target genes (29–32). If the intragenic miRNA is
not an evolutionarily conserved one, cases where the
upregulation of one gene in turn causes, by miRNA-
mediated effects, the downregulation of others should
probably be considered the exception not the rule.
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